• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒病(COVID-19)眼部传播的当前证据:系统评价和荟萃分析。

Current Evidence of 2019 Novel Coronavirus Disease (COVID-19) Ocular Transmission: A Systematic Review and Meta-Analysis.

机构信息

Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.

Department of Ophthalmology, University of California, San Francisco, San Francisco, CA 94143, USA.

出版信息

Biomed Res Int. 2020 Oct 24;2020:7605453. doi: 10.1155/2020/7605453. eCollection 2020.

DOI:10.1155/2020/7605453
PMID:33134387
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7588829/
Abstract

OBJECTIVE

To estimate the prevalence rate of ocular symptoms and the positive rate of conjunctival swab samples of patients diagnosed with 2019 Novel Coronavirus Disease (COVID-19).

METHODS

We performed a systematic review and meta-analysis. A comprehensive literature search was done based on PubMed, Embase, MedRxiv, and the Cochrane Library. The primary outcomes are the prevalence rate of conjunctivitis/conjunctival congestion and the positive rate of conjunctival swab samples. Rates were expressed as proportions with 95% confidence intervals (CIs).

RESULTS

A total of 12 studies with 1930 participants were included for meta-analysis. The pooled prevalence rate of conjunctivitis/conjunctival congestion was 8% (95% CI: 5%-12%). 1% (95% CI: 1%-4%) of COVID-19 patients were diagnosed with conjunctivitis/conjunctival congestion as the initial symptom. The pooled positive rate of conjunctival swab samples was 3% (95% CI: 2%-5%). We also assessed other ocular symptoms reported in the 12 studies, including foreign body sensation, increased secretion, and eye itching. The pooled prevalence rates were 6% (95% CI: 3%-10%), 10% (95% CI: 8%-12%), and 9% (95% CI: 7%-10%), respectively.

CONCLUSIONS

The evidence on the positive rate of conjunctival swab samples and the prevalence rates of ocular symptoms indicated that COVID-19 ocular transmission was possible but less likely.

摘要

目的

估计新型冠状病毒病(COVID-19)患者眼部症状的患病率和结膜拭子样本的阳性率。

方法

我们进行了系统评价和荟萃分析。根据 PubMed、Embase、MedRxiv 和 Cochrane Library 进行了全面的文献检索。主要结局是结膜炎/结膜充血的患病率和结膜拭子样本的阳性率。用 95%置信区间(CI)表示率的比例。

结果

共纳入 12 项研究,共 1930 名参与者进行荟萃分析。结膜炎/结膜充血的总患病率为 8%(95%CI:5%-12%)。1%(95%CI:1%-4%)的 COVID-19 患者以结膜炎/结膜充血为首发症状。结膜拭子样本的总阳性率为 3%(95%CI:2%-5%)。我们还评估了 12 项研究中报告的其他眼部症状,包括异物感、分泌物增加和眼痒。其总患病率分别为 6%(95%CI:3%-10%)、10%(95%CI:8%-12%)和 9%(95%CI:7%-10%)。

结论

结膜拭子样本的阳性率和眼部症状的患病率表明 COVID-19 可能通过眼部传播,但不太可能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67c8/7588829/c5c2752f03f8/BMRI2020-7605453.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67c8/7588829/320037ca839b/BMRI2020-7605453.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67c8/7588829/628080b1d7de/BMRI2020-7605453.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67c8/7588829/88fba78cd73d/BMRI2020-7605453.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67c8/7588829/92418c772534/BMRI2020-7605453.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67c8/7588829/bfe8650900b1/BMRI2020-7605453.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67c8/7588829/49d4ceb94cb0/BMRI2020-7605453.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67c8/7588829/c5c2752f03f8/BMRI2020-7605453.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67c8/7588829/320037ca839b/BMRI2020-7605453.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67c8/7588829/628080b1d7de/BMRI2020-7605453.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67c8/7588829/88fba78cd73d/BMRI2020-7605453.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67c8/7588829/92418c772534/BMRI2020-7605453.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67c8/7588829/bfe8650900b1/BMRI2020-7605453.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67c8/7588829/49d4ceb94cb0/BMRI2020-7605453.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67c8/7588829/c5c2752f03f8/BMRI2020-7605453.007.jpg

相似文献

1
Current Evidence of 2019 Novel Coronavirus Disease (COVID-19) Ocular Transmission: A Systematic Review and Meta-Analysis.新型冠状病毒病(COVID-19)眼部传播的当前证据:系统评价和荟萃分析。
Biomed Res Int. 2020 Oct 24;2020:7605453. doi: 10.1155/2020/7605453. eCollection 2020.
2
Pooled Prevalence Estimate of Ocular Manifestations in COVID-19 Patients: A Systematic Review and Meta-Analysis.COVID-19 患者眼部表现的汇总患病率估计:系统评价和荟萃分析。
Iran J Med Sci. 2022 Jan;47(1):2-14. doi: 10.30476/ijms.2021.89475.2026.
3
Ocular manifestations in COVID-19 patients: A systematic review and meta-analysis.新型冠状病毒肺炎患者的眼部表现:系统评价和荟萃分析。
Travel Med Infect Dis. 2021 Nov-Dec;44:102191. doi: 10.1016/j.tmaid.2021.102191. Epub 2021 Nov 8.
4
SARS-CoV-2 on Ocular Surfaces in a Cohort of Patients With COVID-19 From the Lombardy Region, Italy.意大利伦巴第地区 COVID-19 患者队列中眼表面的 SARS-CoV-2。
JAMA Ophthalmol. 2021 Sep 1;139(9):956-963. doi: 10.1001/jamaophthalmol.2020.5464.
5
Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study.中国武汉 535 例 COVID-19 的眼部表现和临床特征:一项横断面研究。
Acta Ophthalmol. 2020 Dec;98(8):e951-e959. doi: 10.1111/aos.14472. Epub 2020 May 18.
6
Ocular tropism of coronavirus (CoVs): a comparison of the interaction between the animal-to-human transmitted coronaviruses (SARS-CoV-1, SARS-CoV-2, MERS-CoV, CoV-229E, NL63, OC43, HKU1) and the eye.冠状病毒的眼部趋向性:人畜传播冠状病毒(SARS-CoV-1、SARS-CoV-2、MERS-CoV、CoV-229E、NL63、OC43、HKU1)与眼睛相互作用的比较。
Int Ophthalmol. 2021 Jan;41(1):349-362. doi: 10.1007/s10792-020-01575-2. Epub 2020 Sep 3.
7
Detecting SARS-CoV-2 RNA in conjunctival secretions: Is it a valuable diagnostic method of COVID-19?检测结膜分泌物中的 SARS-CoV-2 RNA:这是 COVID-19 的一种有价值的诊断方法吗?
J Med Virol. 2021 Jan;93(1):383-388. doi: 10.1002/jmv.26219. Epub 2020 Jul 6.
8
Presence of viral RNA of SARS-CoV-2 in conjunctival swab specimens of COVID-19 patients.SARS-CoV-2 的病毒 RNA 存在于 COVID-19 患者的结膜拭子标本中。
Indian J Ophthalmol. 2020 Jun;68(6):1015-1017. doi: 10.4103/ijo.IJO_1287_20.
9
Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China.中国湖北省 2019 年冠状病毒病(COVID-19)患者的眼部表现特征。
JAMA Ophthalmol. 2020 May 1;138(5):575-578. doi: 10.1001/jamaophthalmol.2020.1291.
10
COVID-19-related Conjunctivitis Review: Clinical Features and Management.COVID-19 相关结膜炎综述:临床特征与管理。
Ocul Immunol Inflamm. 2023 May;31(4):778-784. doi: 10.1080/09273948.2022.2054432. Epub 2022 Apr 8.

引用本文的文献

1
Changes in the spectrum of ocular disease during the COVID-19 pandemic in late 2022 in the Hubei Province.2022年末湖北省新冠疫情期间眼部疾病谱的变化
Sci Rep. 2025 Feb 21;15(1):6297. doi: 10.1038/s41598-025-89791-7.
2
Acute primary angle closure concurrent with coronavirus disease 2019 recurrence in Northern China: A retrospective multi-centre study.中国北方急性原发性闭角型青光眼与2019冠状病毒病复发并存:一项回顾性多中心研究。
Heliyon. 2024 Jul 4;10(13):e34090. doi: 10.1016/j.heliyon.2024.e34090. eCollection 2024 Jul 15.
3
Does SARS-CoV-2 infection cause persistent ocular symptoms?: A cross-sectional study after the lifting of lockdown in Chongqing, China.

本文引用的文献

1
Atlas of ACE2 gene expression reveals novel insights into transmission of SARS-CoV-2.血管紧张素转换酶2(ACE2)基因表达图谱揭示了严重急性呼吸综合征冠状病毒2(SARS-CoV-2)传播的新见解。
Heliyon. 2021 Jan;7(1):e05850. doi: 10.1016/j.heliyon.2020.e05850. Epub 2020 Dec 26.
2
Ocular conjunctival inoculation of SARS-CoV-2 can cause mild COVID-19 in rhesus macaques.眼结膜接种 SARS-CoV-2 可在恒河猴中引起轻度 COVID-19。
Nat Commun. 2020 Sep 2;11(1):4400. doi: 10.1038/s41467-020-18149-6.
3
Conjunctivitis in COVID-19 patients: frequency and clinical presentation.
SARS-CoV-2 感染是否会导致持续性眼部症状?:中国重庆解除封锁后的横断面研究。
Medicine (Baltimore). 2023 Dec 22;102(51):e36798. doi: 10.1097/MD.0000000000036798.
4
Incidence and clinical characteristic of ocular surface manifestation: an evaluation of conjunctival swab results in Corona Virus 2019 (COVID-19) patients in Jakarta, Indonesia.眼表表现的发病率及临床特征:对印度尼西亚雅加达2019冠状病毒病(COVID-19)患者结膜拭子结果的评估
J Ophthalmic Inflamm Infect. 2023 Apr 25;13(1):20. doi: 10.1186/s12348-023-00343-4.
5
Covid-19 and its relation to the human eye: transmission, infection, and ocular manifestations.Covid-19 及其与人类眼睛的关系:传播、感染和眼部表现。
Graefes Arch Clin Exp Ophthalmol. 2023 Jul;261(7):1771-1780. doi: 10.1007/s00417-022-05954-6. Epub 2022 Dec 31.
6
Emphasis on heat strain to the ocular surface: A functional and clinical study of a modified goggle.强调对眼表面的热应激:改良护目镜的功能和临床研究。
Front Public Health. 2022 Aug 2;10:955443. doi: 10.3389/fpubh.2022.955443. eCollection 2022.
7
A Systematic Literature Review and Bibliometric Analysis of Ophthalmology and COVID-19 Research.眼科与新冠肺炎研究的系统文献综述和文献计量分析
J Ophthalmol. 2022 May 24;2022:8195228. doi: 10.1155/2022/8195228. eCollection 2022.
8
Systematic review: SARS-COV-2 contagion prevention measures in vision health professionals.系统评价:视力保健专业人员中预防SARS-CoV-2感染的措施
Oman J Ophthalmol. 2021 Oct 20;14(3):136-143. doi: 10.4103/ojo.ojo_134_21. eCollection 2021 Sep-Dec.
9
Ocular manifestations in COVID-19 patients: A systematic review and meta-analysis.新型冠状病毒肺炎患者的眼部表现:系统评价和荟萃分析。
Travel Med Infect Dis. 2021 Nov-Dec;44:102191. doi: 10.1016/j.tmaid.2021.102191. Epub 2021 Nov 8.
10
Conjunctivitis and other ocular findings in patients with COVID-19 infection.COVID-19 感染患者的结膜炎及其他眼部表现。
Ann Saudi Med. 2021 Sep-Oct;41(5):280-284. doi: 10.5144/0256-4947.2021.280. Epub 2021 Oct 7.
COVID-19 患者的结膜炎:频率和临床表现。
Graefes Arch Clin Exp Ophthalmol. 2020 Nov;258(11):2501-2507. doi: 10.1007/s00417-020-04916-0. Epub 2020 Aug 29.
4
Ocular Manifestations and Clinical Characteristics of Children With Laboratory-Confirmed COVID-19 in Wuhan, China.中国武汉实验室确诊 COVID-19 患儿的眼部表现和临床特征。
JAMA Ophthalmol. 2020 Oct 1;138(10):1079-1086. doi: 10.1001/jamaophthalmol.2020.3690.
5
More than loss of taste and smell: burning watering eyes in coronavirus disease 2019.不止是失去味觉和嗅觉:2019 冠状病毒病患者的眼睛灼热且流泪。
Clin Microbiol Infect. 2020 Nov;26(11):1560.e5-1560.e8. doi: 10.1016/j.cmi.2020.08.018. Epub 2020 Aug 21.
6
Ocular findings in patients with coronavirus disease 2019 (COVID-19) in an outbreak hospital.在一家暴发医院中,2019 年冠状病毒病(COVID-19)患者的眼部表现。
J Med Virol. 2021 Feb;93(2):1126-1132. doi: 10.1002/jmv.26412. Epub 2020 Aug 21.
7
Clinical profile and prevalence of conjunctivitis in mild COVID-19 patients in a tertiary care COVID-19 hospital: A retrospective cross-sectional study.
Indian J Ophthalmol. 2020 Aug;68(8):1546-1550. doi: 10.4103/ijo.IJO_1319_20.
8
Detection of severe acute respiratory syndrome Coronavirus-2 in the tears of patients with Coronavirus disease 2019.检测严重急性呼吸综合征冠状病毒-2 在 2019 年冠状病毒病患者的眼泪中。
Eye (Lond). 2020 Jul;34(7):1220-1223. doi: 10.1038/s41433-020-0965-2. Epub 2020 May 18.
9
Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study.中国武汉 535 例 COVID-19 的眼部表现和临床特征:一项横断面研究。
Acta Ophthalmol. 2020 Dec;98(8):e951-e959. doi: 10.1111/aos.14472. Epub 2020 May 18.
10
Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea.SARS-CoV-2 受体 ACE2 和 TMPRSS2 在人原发性结膜和翼状胬肉细胞系以及小鼠角膜中的表达。
Eye (Lond). 2020 Jul;34(7):1212-1219. doi: 10.1038/s41433-020-0939-4. Epub 2020 May 7.